Welcome to the UCL Cancer Institute
The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing better, more effective treatments to improve outcomes for cancer patients. If you are considering postgraduate study with us, applications to our flagship MSc Cancer programme are open until 29th July 2016 for September entry.
This year’s Cancer Research UK Pontecorvo prize for Best PhD Thesis has been awarded to Dr Nicholas McGranahan, who is currently a postdoc with Professor Charles Swanton (UCL Cancer Institute and the Francis Crick Institute). This prestigious prize is awarded to Cancer Research UK-funded students who have produced outstanding PhD theses and made the greatest contribution to scientific knowledge in their field.
Published: Jul 27, 2016 12:24:06 PM
Safer precision radiotherapies that will be able to cure more cancers with fewer side-effects will be available within five years under ambitious new plans for research and treatment at the UCL Cancer Institute and University College London Hospitals (UCLH) NHS Foundation Trust. Today, UCL and UCLH welcome Professor Ricky Sharma, a world-leading oncologist from Oxford University specialising in radiotherapy and cancer biology, to lead the new clinical research programme alongside a team of top physicists.
Published: Jul 4, 2016 2:37:19 PM
An international research collaboration led by UCL scientists has developed ways to improve the quality and accuracy of information harvested from epigenome sequencing datasets in two new research papers published jointly in Nature Biotechnology and Nature Communications today. According to the studies, epigenome sequencing technologies can allow for more comprehensive analysis of cancers - a key component in the development of targeted approaches to combat cancer.
Published: Jun 27, 2016 5:09:23 PM
The final stages of an £8.9 million award to advance cancer medical research facilities at UCL/UCLH, were celebrated last night with a launch event marking the implementation of new cancer genomics and imaging technologies that will support two world-class cancer research programmes. The event, hosted at the UCL Cancer Institute, featured keynote speeches from Dr Jim Smith, MRC Deputy Chief Executive and Chief of Strategy and Professors Mark Emberton, Tim Meyer and Tariq Enver, who will be leading the research projects at UCLH and UCL.
Published: Jun 16, 2016 3:16:06 PM
Support our work
The progress we make in understanding and developing treatments for cancer is made possible by the generous support of individuals, companies and charitable trusts and foundations. Our donors support us every step of the way in the ongoing fight against cancer.
Find out more about how you can help us to continue research that will lead to breakthroughs in cancer therapies and benefit the lives of cancer patients.